Mel Ziman or M. Ziman or M.R. Ziman or MR Ziman or M Ziman or Melanie Ziman
Mel Ziman or M. Ziman or M.R. Ziman or MR Ziman or M Ziman or Melanie Ziman
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Nestin structure and predicted function in cellular cytoskeletal organisation
K Michalczyk, M Ziman
Histology and histopathology, 2005
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
ES Gray, H Rizos, AL Reid, SC Boyd, MR Pereira, J Lo, V Tembe, ...
Oncotarget 6 (39), 42008, 2015
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria
PN Meissner, TA Dailey, RJ Hift, M Ziman, AV Corrigall, AG Roberts, ...
Nature genetics 13 (1), 95-97, 1996
Pax genes: regulators of lineage specification and progenitor cell maintenance
JA Blake, MR Ziman
Development 141 (4), 737-751, 2014
Serologic autoantibodies as diagnostic cancer biomarkers—a review
P Zaenker, MR Ziman
Cancer Epidemiology and Prevention Biomarkers 22 (12), 2161-2181, 2013
Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?
E Charytonowicz, C Cordon-Cardo, I Matushansky, M Ziman
Cancer letters 279 (2), 126-136, 2009
Autoantibody production in cancer—the humoral immune response toward autologous antigens in cancer patients
P Zaenker, ES Gray, MR Ziman
Autoimmunity reviews 15 (5), 477-483, 2016
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease
TM Cruickshank, AR Reyes, MR Ziman
Medicine 94 (4), 2015
Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
AL Reid, JB Freeman, M Millward, M Ziman, ES Gray
Clinical biochemistry 48 (15), 999-1002, 2015
Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma
L Calapre, L Warburton, M Millward, M Ziman, ES Gray
Cancer letters 404, 62-69, 2017
The effects of multidisciplinary rehabilitation in patients with early‐to‐middle‐stage Huntington's disease: a pilot study
JA Thompson, TM Cruickshank, LE Penailillo, JW Lee, RU Newton, ...
European Journal of Neurology 20 (9), 1325-1329, 2013
Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression
AL Reid, M Millward, R Pearce, M Lee, MH Frank, A Ireland, ...
British Journal of Dermatology 168 (1), 85-92, 2013
Inhaled methoxyflurane and intranasal fentanyl for prehospital management of visceral pain in an Australian ambulance service
S Johnston, GJ Wilkes, JA Thompson, M Ziman, R Brightwell
Emergency Medicine Journal 28 (1), 57-63, 2011
The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease: an exploratory study
TM Cruickshank, JA Thompson, JF Domínguez D, AP Reyes, M Bynevelt, ...
Brain and Behavior 5 (2), e00312, 2015
Pax genes during neural development and their potential role in neuroregeneration
JA Thompson, M Ziman
Progress in neurobiology 95 (3), 334-351, 2011
PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas)
S Medic, M Ziman
PloS one 5 (4), e9977, 2010
Circulating melanoma cell subpopulations: their heterogeneity and differential responses to treatment
ES Gray, AL Reid, S Bowyer, L Calapre, K Siew, R Pearce, L Cowell, ...
Journal of Investigative Dermatology 135 (8), 2040-2048, 2015
Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review
A Reyes, M Ziman, K Nosaka
Chest 143 (5), 1386-1394, 2013
Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells
JB Freeman, ES Gray, M Millward, R Pearce, M Ziman
Journal of translational medicine 10 (1), 1-9, 2012
Perplexing Pax: from puzzle to paradigm
JA Blake, M Thomas, JA Thompson, R White, M Ziman
Developmental Dynamics 237 (10), 2791-2803, 2008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20